25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

WINDLAS (Windlas) Stock Analysis
Buy, Hold or Sell?

Let's analyze Windlas together

I guess you are interested in Windlas Biotech Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Windlas’s Financial Insights
  • 📈 Technical Analysis (TA) – Windlas’s Price Targets

I'm going to help you getting a better view of Windlas Biotech Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Windlas Biotech Ltd

I send you an email if I find something interesting about Windlas Biotech Ltd.

1. Quick Overview

1.1. Quick analysis of Windlas (30 sec.)










1.2. What can you expect buying and holding a share of Windlas? (30 sec.)

How much money do you get?

How much money do you get?
INR0.26
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
INR241.31
Expected worth in 1 year
INR347.87
How sure are you?
83.3%

+ What do you gain per year?

Total Gains per Share
INR128.50
Return On Investment
14.3%

For what price can you sell your share?

Current Price per Share
INR898.45
Expected price per share
INR792.05 - INR1,039
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Windlas (5 min.)




Live pricePrice per Share (EOD)
INR898.45
Intrinsic Value Per Share
INR77.80 - INR257.89
Total Value Per Share
INR319.11 - INR499.20

2.2. Growth of Windlas (5 min.)




Is Windlas growing?

Current yearPrevious yearGrowGrow %
How rich?$59.1m$52.6m$6.5m11.0%

How much money is Windlas making?

Current yearPrevious yearGrowGrow %
Making money$7.1m$6.8m$328.4k4.6%
Net Profit Margin8.0%9.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Windlas (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Windlas?

Welcome investor! Windlas's management wants to use your money to grow the business. In return you get a share of Windlas.

First you should know what it really means to hold a share of Windlas. And how you can make/lose money.

Speculation

The Price per Share of Windlas is INR898.45. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Windlas.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Windlas, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR241.31. Based on the TTM, the Book Value Change Per Share is INR26.64 per quarter. Based on the YOY, the Book Value Change Per Share is INR22.74 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR5.48 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Windlas.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.340.0%0.340.0%0.320.0%0.300.0%0.240.0%0.210.0%
Usd Book Value Change Per Share0.310.0%0.310.0%0.270.0%0.230.0%0.340.0%0.470.1%
Usd Dividend Per Share0.060.0%0.060.0%0.050.0%0.050.0%0.030.0%0.030.0%
Usd Total Gains Per Share0.380.0%0.380.0%0.310.0%0.290.0%0.370.0%0.500.1%
Usd Price Per Share12.18-12.18-5.99-6.94-4.65-3.88-
Price to Earnings Ratio35.78-35.78-18.46-21.77-15.47-12.89-
Price-to-Total Gains Ratio32.41-32.41-19.19-22.40-17.39-17.39-
Price to Book Ratio4.31-4.31-2.39-2.62-1.81-1.51-
Price-to-Total Gains Ratio32.41-32.41-19.19-22.40-17.39-17.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share10.511865
Number of shares95
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.060.03
Usd Book Value Change Per Share0.310.34
Usd Total Gains Per Share0.380.37
Gains per Quarter (95 shares)35.7135.17
Gains per Year (95 shares)142.83140.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12411813312129131
24923727623258272
37335541935387413
49847456247516554
512259270558645695
614671184870774836
717182999181903977
819594811349310321118
92191066127710511611259
102441184142011612901400

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%5.01.00.083.3%5.01.00.083.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%3.00.02.060.0%3.00.03.050.0%3.00.03.050.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%5.01.00.083.3%5.01.00.083.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Windlas Biotech Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--26.64026.6400%22.742+17%20.058+33%29.023-8%40.219-34%
Book Value Per Share--241.311241.3110%214.671+12%215.971+12%184.082+31%169.435+42%
Current Ratio--2.1052.1050%2.511-16%2.511-16%2.735-23%2.502-16%
Debt To Asset Ratio--0.3350.3350%0.281+19%0.285+17%0.276+21%0.293+14%
Debt To Equity Ratio--0.5040.5040%0.392+29%0.403+25%0.388+30%0.426+18%
Dividend Per Share--5.4845.4840%3.961+38%4.361+26%2.617+110%2.181+151%
Enterprise Value--19276054613.20019276054613.2000%8975797355.000+115%10568282109.400+82%8830376128.925+118%8830376128.925+118%
Eps--29.10129.1010%27.762+5%25.734+13%20.388+43%18.230+60%
Ev To Sales Ratio--2.5372.5370%1.423+78%1.545+64%1.354+87%1.354+87%
Free Cash Flow Per Share--7.6307.6300%34.007-78%12.301-38%7.374+3%6.887+11%
Free Cash Flow To Equity Per Share--7.6307.6300%34.007-78%12.301-38%19.383-61%16.478-54%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--257.887----------
Intrinsic Value_10Y_min--77.795----------
Intrinsic Value_1Y_max--15.254----------
Intrinsic Value_1Y_min--7.557----------
Intrinsic Value_3Y_max--53.902----------
Intrinsic Value_3Y_min--23.047----------
Intrinsic Value_5Y_max--102.279----------
Intrinsic Value_5Y_min--38.792----------
Market Cap18830883085.000-16%21822834613.20021822834613.2000%10738497355.000+103%12427122109.400+76%8372072903.140+161%6976727419.283+213%
Net Profit Margin--0.0800.0800%0.092-13%0.085-6%0.075+7%0.071+13%
Operating Margin----0%-0%-0%0.038-100%0.048-100%
Operating Ratio--1.5341.5340%1.525+1%1.5340%1.5420%1.542-1%
Pb Ratio3.723-16%4.3154.3150%2.387+81%2.625+64%1.807+139%1.506+187%
Pe Ratio30.873-16%35.77935.7790%18.455+94%21.769+64%15.466+131%12.888+178%
Price Per Share898.450-16%1041.2001041.2000%512.350+103%592.917+76%397.770+162%331.475+214%
Price To Free Cash Flow Ratio117.745-16%136.452136.4520%15.066+806%34.654+294%4.652+2833%3.877+3420%
Price To Total Gains Ratio27.968-16%32.41132.4110%19.188+69%22.401+45%17.386+86%17.386+86%
Quick Ratio--1.6311.6310%1.953-16%1.868-13%1.982-18%1.767-8%
Return On Assets--0.0800.0800%0.093-14%0.085-5%0.077+4%0.072+11%
Return On Equity--0.1210.1210%0.129-7%0.119+2%0.106+13%0.102+19%
Total Gains Per Share--32.12532.1250%26.702+20%24.420+32%31.639+2%42.399-24%
Usd Book Value--59175324.00059175324.0000%52642512.000+12%52961181.000+12%45673875.000+30%42149913.000+40%
Usd Book Value Change Per Share--0.3120.3120%0.266+17%0.235+33%0.340-8%0.471-34%
Usd Book Value Per Share--2.8232.8230%2.512+12%2.527+12%2.154+31%1.982+42%
Usd Dividend Per Share--0.0640.0640%0.046+38%0.051+26%0.031+110%0.026+151%
Usd Enterprise Value--225529838.974225529838.9740%105016829.054+115%123648900.680+82%103315400.708+118%103315400.708+118%
Usd Eps--0.3400.3400%0.325+5%0.301+13%0.239+43%0.213+60%
Usd Free Cash Flow--1871181.0001871181.0000%8339292.000-78%3016416.000-38%1808281.800+3%1695973.500+10%
Usd Free Cash Flow Per Share--0.0890.0890%0.398-78%0.144-38%0.086+3%0.081+11%
Usd Free Cash Flow To Equity Per Share--0.0890.0890%0.398-78%0.144-38%0.227-61%0.193-54%
Usd Market Cap220321332.095-16%255327164.974255327164.9740%125640419.054+103%145397328.680+76%97953252.967+161%81627710.806+213%
Usd Price Per Share10.512-16%12.18212.1820%5.994+103%6.937+76%4.654+162%3.878+214%
Usd Profit--7136298.0007136298.0000%6807879.000+5%6310473.000+13%5048035.200+41%4522849.500+58%
Usd Revenue--88905726.00088905726.0000%73821852.000+20%74155185.000+20%65321100.000+36%60838635.000+46%
Usd Total Gains Per Share--0.3760.3760%0.312+20%0.286+32%0.370+2%0.496-24%
 EOD+4 -4MRQTTM+0 -0YOY+20 -173Y+22 -155Y+25 -1310Y+23 -15

3.3 Fundamental Score

Let's check the fundamental score of Windlas Biotech Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1530.873
Price to Book Ratio (EOD)Between0-13.723
Net Profit Margin (MRQ)Greater than00.080
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.631
Current Ratio (MRQ)Greater than12.105
Debt to Asset Ratio (MRQ)Less than10.335
Debt to Equity Ratio (MRQ)Less than10.504
Return on Equity (MRQ)Greater than0.150.121
Return on Assets (MRQ)Greater than0.050.080
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Windlas Biotech Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.586
Ma 20Greater thanMa 50899.640
Ma 50Greater thanMa 100927.376
Ma 100Greater thanMa 200926.529
OpenGreater thanClose906.350
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Windlas Biotech Ltd

Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids. Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India.

Fundamental data was last updated by Penke on 2025-06-21 00:26:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Windlas earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Windlas to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 8.0% means that ₹0.08 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Windlas Biotech Ltd:

  • The MRQ is 8.0%. The company is making a profit. +1
  • The TTM is 8.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.0%TTM8.0%0.0%
TTM8.0%YOY9.2%-1.2%
TTM8.0%5Y7.5%+0.5%
5Y7.5%10Y7.1%+0.4%
4.3.1.2. Return on Assets

Shows how efficient Windlas is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Windlas to the Drug Manufacturers - Specialty & Generic industry mean.
  • 8.0% Return on Assets means that Windlas generated ₹0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Windlas Biotech Ltd:

  • The MRQ is 8.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 8.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ8.0%TTM8.0%0.0%
TTM8.0%YOY9.3%-1.3%
TTM8.0%5Y7.7%+0.3%
5Y7.7%10Y7.2%+0.5%
4.3.1.3. Return on Equity

Shows how efficient Windlas is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Windlas to the Drug Manufacturers - Specialty & Generic industry mean.
  • 12.1% Return on Equity means Windlas generated ₹0.12 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Windlas Biotech Ltd:

  • The MRQ is 12.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 12.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.1%TTM12.1%0.0%
TTM12.1%YOY12.9%-0.9%
TTM12.1%5Y10.6%+1.4%
5Y10.6%10Y10.2%+0.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Windlas Biotech Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Windlas is operating .

  • Measures how much profit Windlas makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Windlas to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Windlas Biotech Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y3.8%-3.8%
5Y3.8%10Y4.8%-1.0%
4.3.2.2. Operating Ratio

Measures how efficient Windlas is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.53 means that the operating costs are ₹1.53 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Windlas Biotech Ltd:

  • The MRQ is 1.534. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.534. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.534TTM1.5340.000
TTM1.534YOY1.525+0.009
TTM1.5345Y1.542-0.008
5Y1.54210Y1.542-0.001
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Windlas Biotech Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Windlas is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.11 means the company has ₹2.11 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Windlas Biotech Ltd:

  • The MRQ is 2.105. The company is able to pay all its short-term debts. +1
  • The TTM is 2.105. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.105TTM2.1050.000
TTM2.105YOY2.511-0.406
TTM2.1055Y2.735-0.629
5Y2.73510Y2.502+0.232
4.4.3.2. Quick Ratio

Measures if Windlas is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Windlas to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.63 means the company can pay off ₹1.63 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Windlas Biotech Ltd:

  • The MRQ is 1.631. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.631. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.631TTM1.6310.000
TTM1.631YOY1.953-0.322
TTM1.6315Y1.982-0.352
5Y1.98210Y1.767+0.215
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Windlas Biotech Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Windlas assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Windlas to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.33 means that Windlas assets are financed with 33.5% credit (debt) and the remaining percentage (100% - 33.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Windlas Biotech Ltd:

  • The MRQ is 0.335. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.335. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.335TTM0.3350.000
TTM0.335YOY0.281+0.053
TTM0.3355Y0.276+0.059
5Y0.27610Y0.293-0.017
4.5.4.2. Debt to Equity Ratio

Measures if Windlas is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Windlas to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 50.4% means that company has ₹0.50 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Windlas Biotech Ltd:

  • The MRQ is 0.504. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.504. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.504TTM0.5040.000
TTM0.504YOY0.392+0.112
TTM0.5045Y0.388+0.115
5Y0.38810Y0.426-0.038
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Windlas generates.

  • Above 15 is considered overpriced but always compare Windlas to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 35.78 means the investor is paying ₹35.78 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Windlas Biotech Ltd:

  • The EOD is 30.873. Based on the earnings, the company is overpriced. -1
  • The MRQ is 35.779. Based on the earnings, the company is overpriced. -1
  • The TTM is 35.779. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD30.873MRQ35.779-4.905
MRQ35.779TTM35.7790.000
TTM35.779YOY18.455+17.324
TTM35.7795Y15.466+20.313
5Y15.46610Y12.888+2.578
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Windlas Biotech Ltd:

  • The EOD is 117.745. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 136.452. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 136.452. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD117.745MRQ136.452-18.708
MRQ136.452TTM136.4520.000
TTM136.452YOY15.066+121.386
TTM136.4525Y4.652+131.800
5Y4.65210Y3.877+0.775
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Windlas is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 4.31 means the investor is paying ₹4.31 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Windlas Biotech Ltd:

  • The EOD is 3.723. Based on the equity, the company is fair priced.
  • The MRQ is 4.315. Based on the equity, the company is fair priced.
  • The TTM is 4.315. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.723MRQ4.315-0.592
MRQ4.315TTM4.3150.000
TTM4.315YOY2.387+1.928
TTM4.3155Y1.807+2.508
5Y1.80710Y1.506+0.301
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets7,604,500
Total Liabilities2,546,780
Total Stockholder Equity5,057,720
 As reported
Total Liabilities 2,546,780
Total Stockholder Equity+ 5,057,720
Total Assets = 7,604,500

Assets

Total Assets7,604,500
Total Current Assets5,251,290
Long-term Assets2,353,210
Total Current Assets
Cash And Cash Equivalents 4,240
Short-term Investments 2,398,720
Net Receivables 1,668,630
Inventory 813,840
Other Current Assets 333,060
Total Current Assets  (as reported)5,251,290
Total Current Assets  (calculated)5,218,490
+/- 32,800
Long-term Assets
Property Plant Equipment 2,219,270
Intangible Assets 67,790
Long-term Assets Other 20,740
Long-term Assets  (as reported)2,353,210
Long-term Assets  (calculated)2,307,800
+/- 45,410

Liabilities & Shareholders' Equity

Total Current Liabilities2,494,430
Long-term Liabilities52,350
Total Stockholder Equity5,057,720
Total Current Liabilities
Short Long Term Debt 271,170
Accounts payable 1,672,370
Other Current Liabilities 127,680
Total Current Liabilities  (as reported)2,494,430
Total Current Liabilities  (calculated)2,071,220
+/- 423,210
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt54,800
Long-term Liabilities  (as reported)52,350
Long-term Liabilities  (calculated)54,800
+/- 2,450
Total Stockholder Equity
Total Stockholder Equity (as reported)5,057,720
Total Stockholder Equity (calculated)0
+/- 5,057,720
Other
Capital Stock104,800
Common Stock Shares Outstanding 20,959
Net Debt 266,930
Net Invested Capital 5,328,890
Net Working Capital 2,756,860
Property Plant and Equipment Gross 2,219,270



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2025-03-312024-03-312023-03-312022-03-312021-03-312020-03-31
> Total Assets 
3,384,880
2,961,230
4,910,110
5,289,750
6,262,060
7,604,500
7,604,5006,262,0605,289,7504,910,1102,961,2303,384,880
   > Total Current Assets 
1,680,290
1,943,110
3,816,510
3,535,360
4,312,860
5,251,290
5,251,2904,312,8603,535,3603,816,5101,943,1101,680,290
       Cash And Cash Equivalents 
180,780
159,300
5,700
36,860
52,880
4,240
4,24052,88036,8605,700159,300180,780
       Short-term Investments 
225,860
383,250
1,754,560
1,282,820
1,990,920
2,398,720
2,398,7201,990,9201,282,8201,754,560383,250225,860
       Net Receivables 
639,380
794,130
1,107,720
1,168,600
1,362,770
1,668,630
1,668,6301,362,7701,168,6001,107,720794,130639,380
       Inventory 
493,170
414,610
587,100
747,380
621,890
813,840
813,840621,890747,380587,100414,610493,170
       Other Current Assets 
136,480
179,420
329,760
285,020
262,170
333,060
333,060262,170285,020329,760179,420136,480
   > Long-term Assets 
1,704,590
1,018,120
1,093,600
1,754,390
1,949,200
2,353,210
2,353,2101,949,2001,754,3901,093,6001,018,1201,704,590
       Property Plant Equipment 
700,640
956,680
984,680
1,614,720
1,851,210
2,219,270
2,219,2701,851,2101,614,720984,680956,680700,640
       Intangible Assets 
5,520
4,820
8,810
14,840
44,680
67,790
67,79044,68014,8408,8104,8205,520
       Other Assets 
61,960
58,350
76,020
0
0
0
00076,02058,35061,960
> Total Liabilities 
1,288,290
970,040
962,340
1,267,040
1,762,700
2,546,780
2,546,7801,762,7001,267,040962,340970,0401,288,290
   > Total Current Liabilities 
1,252,890
934,190
939,860
1,212,420
1,717,510
2,494,430
2,494,4301,717,5101,212,420939,860934,1901,252,890
       Short Long Term Debt 
262,180
304,840
56,770
3,350
1,090
271,170
271,1701,0903,35056,770304,840262,180
       Accounts payable 
831,360
399,330
632,320
877,430
1,315,110
1,672,370
1,672,3701,315,110877,430632,320399,330831,360
       Other Current Liabilities 
16,460
18,260
17,060
41,460
46,730
127,680
127,68046,73041,46017,06018,26016,460
   > Long-term Liabilities 
35,400
35,850
22,480
54,620
45,190
52,350
52,35045,19054,62022,48035,85035,400
       Long term Debt 
12,130
8,320
4,440
1,090
0
0
001,0904,4408,32012,130
       Capital Lease Obligations Min Short Term Debt
15,030
10,330
5,160
45,490
35,320
54,800
54,80035,32045,4905,16010,33015,030
       Other Liabilities 
12,940
22,360
18,030
0
0
0
00018,03022,36012,940
       Long-term Liabilities Other 
0
0
40
0
0
0
0004000
> Total Stockholder Equity
2,096,590
1,991,190
3,947,770
4,022,710
4,499,360
5,057,720
5,057,7204,499,3604,022,7103,947,7701,991,1902,096,590
   Common Stock
64,110
64,110
108,970
0
0
0
000108,97064,11064,110
   Retained Earnings 
1,277,570
1,172,200
1,551,260
1,763,460
2,259,720
0
02,259,7201,763,4601,551,2601,172,2001,277,570
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
0
-30
18,070
0
0
0
00018,070-300



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2025-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue7,598,780
Cost of Revenue-4,718,550
Gross Profit2,880,2302,880,230
 
Operating Income (+$)
Gross Profit2,880,230
Operating Expense-6,937,560
Operating Income661,220-4,057,330
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense6,937,5600
 
Net Interest Income (+$)
Interest Income0
Interest Expense-43,820
Other Finance Cost-0
Net Interest Income-43,820
 
Pretax Income (+$)
Operating Income661,220
Net Interest Income-43,820
Other Non-Operating Income Expenses0
Income Before Tax (EBT)797,580661,220
EBIT - interestExpense = -43,820
609,940
653,760
Interest Expense43,820
Earnings Before Interest and Taxes (EBIT)0841,400
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax797,580
Tax Provision-187,640
Net Income From Continuing Ops609,940609,940
Net Income609,940
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net043,820
 

Technical Analysis of Windlas
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Windlas. The general trend of Windlas is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Windlas's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Windlas Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Windlas Biotech Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 942.20 < 954.25 < 1,039.

The bearish price targets are: 872.00 > 866.75 > 792.05.

Know someone who trades $WINDLAS? Share this with them.👇

Windlas Biotech Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Windlas Biotech Ltd. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Windlas Biotech Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Windlas Biotech Ltd. The current macd is -5.29682441.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Windlas price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Windlas. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Windlas price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Windlas Biotech Ltd Daily Moving Average Convergence/Divergence (MACD) ChartWindlas Biotech Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Windlas Biotech Ltd. The current adx is 11.04.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Windlas shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Windlas Biotech Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Windlas Biotech Ltd. The current sar is 876.16.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Windlas Biotech Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Windlas Biotech Ltd. The current rsi is 46.59. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Windlas Biotech Ltd Daily Relative Strength Index (RSI) ChartWindlas Biotech Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Windlas Biotech Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Windlas price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Windlas Biotech Ltd Daily Stochastic Oscillator ChartWindlas Biotech Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Windlas Biotech Ltd. The current cci is -21.20811287.

Windlas Biotech Ltd Daily Commodity Channel Index (CCI) ChartWindlas Biotech Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Windlas Biotech Ltd. The current cmo is -5.8695602.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Windlas Biotech Ltd Daily Chande Momentum Oscillator (CMO) ChartWindlas Biotech Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Windlas Biotech Ltd. The current willr is -60.01371742.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Windlas is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Windlas Biotech Ltd Daily Williams %R ChartWindlas Biotech Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Windlas Biotech Ltd.

Windlas Biotech Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Windlas Biotech Ltd. The current atr is 30.10.

Windlas Biotech Ltd Daily Average True Range (ATR) ChartWindlas Biotech Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Windlas Biotech Ltd. The current obv is 739,380.

Windlas Biotech Ltd Daily On-Balance Volume (OBV) ChartWindlas Biotech Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Windlas Biotech Ltd. The current mfi is 34.31.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Windlas Biotech Ltd Daily Money Flow Index (MFI) ChartWindlas Biotech Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Windlas Biotech Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Windlas Biotech Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Windlas Biotech Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.586
Ma 20Greater thanMa 50899.640
Ma 50Greater thanMa 100927.376
Ma 100Greater thanMa 200926.529
OpenGreater thanClose906.350
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Windlas with someone you think should read this too:
  • Are you bullish or bearish on Windlas? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Windlas? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Windlas Biotech Ltd

I send you an email if I find something interesting about Windlas Biotech Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Windlas Biotech Ltd.

Receive notifications about Windlas Biotech Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.